POLBF (Poolbeg Pharma) Pre-Tax Income: $-7.77 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Poolbeg Pharma Pre-Tax Income?

Poolbeg Pharma POLBF +0.84% Pre-Tax Income is $-7.77 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Pretax income is the income that a company earns before paying income taxes. Poolbeg Pharma's pretax income for the six months ended in Dec. 2025 was $-4.74 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2025 was $-7.77 Mil. Poolbeg Pharma's pretax margin was %.

Poolbeg Pharma  (OTCPK:POLBF) Pre-Tax Income Explanation

Poolbeg Pharma's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pretax Income/Revenue
=-4.74/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poolbeg Pharma Pre-Tax Income Related Terms

Poolbeg Pharma Pre-Tax Income Historical Data

* Premium members only.

The historical data trend for Poolbeg Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poolbeg Pharma Pre-Tax Income Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Pre-Tax Income
-3.11 -5.82 -5.70 -7.52 -7.73

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only -3.41 -2.91 -4.63 -3.03 -4.74

POLBF vs VRTX, REGN, RVMD: Pre-Tax Income Comparison

For the Biotechnology subindustry, Poolbeg Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poolbeg Pharma Pre-Tax Income vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Poolbeg Pharma's Pre-Tax Income falls into.


Poolbeg Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Poolbeg Pharma's Pretax Income for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-8.027+0+0+0.339+-0.042000000000002
=-7.73

Poolbeg Pharma's Pretax Income for the quarter that ended in Dec. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-4.882+0+0+0.183+-0.041
=-4.74

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-7.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pre-Tax Income →
What does a Pre-Tax Income of $-7.77 Mil mean?
Poolbeg Pharma (POLBF) has a Pre-Tax Income of $-7.77 Mil as of Dec. 2025. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Poolbeg Pharma and its competitors.
Is Poolbeg Pharma's Pre-Tax Income too high?
Poolbeg Pharma's current Pre-Tax Income is $-7.77 Mil.
How does Poolbeg Pharma's Pre-Tax Income compare to VRTX and REGN?
Poolbeg Pharma's Pre-Tax Income of $-7.77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Poolbeg Pharma and its competitors. Poolbeg Pharma's current Pre-Tax Income is $-7.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poolbeg Pharma stock overvalued right now?
Poolbeg Pharma (POLBF) has a current Pre-Tax Income of $-7.77 Mil. The current Pre-Tax Income is $-7.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Poolbeg Pharma (POLBF), the current Pre-Tax Income is $-7.77 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poolbeg Pharma Business Description

Other Exchanges POLB:UK7JN:Germany
Address 20 St. Andrew Street, The Clubhouse Holborn, London, GBR, EC4A 3AG
Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. The Company's main asset, POLB 001, has the potential to expand administration of cancer immunotherapies from centralised specialist cancer centres into community hospitals by making the treatments safer through the prevention of the life-threatening side effect, Cytokine Release Syndrome (CRS). The group is also advancing the development of a patient-friendly therapy for obesity with an oral encapsulated GLP-1, offering a differentiated approach within one of the world's markets. It is focused on partnering its high-value programmes that are targeting large markets and addressing critical unmet medical needs.